Frontiers
US$ 23.98
retatrutide and blood sugar Diagram showing the mechanism of action of Retatrutide vs Tirzepatide — Key
Description
Emugrobart (Roche / Genentech) Current Status: Terminated (in rare disease)
Am J Clin Nutr 2010
V thi gian ti u s dng GLP-1, hin cha c s liu chnh xc v cn thm nghin cu di hn nh gi hiu qu gim cn bn vng
it may only be used lawfully within an authorised clinical trial or MHRA-regulated framework
Product Comparison Note: Data sourced from supplier profiles and price tier tables provided
